» Articles » PMID: 31911565

Assessment of Left Ventricular Function in Type 2 Diabetes Mellitus Patients with Non-alcoholic Fatty Liver Disease Using Three-dimensional Speckle-tracking Echocardiography

Overview
Publisher Kare Publishing
Date 2020 Jan 9
PMID 31911565
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Using three-dimensional speckle-tracking echocardiography (3D-STE), we aimed to evaluate left ventricular (LV) function in type 2 diabetes mellitus (T2DM) patients with non-alcoholic fatty liver disease (NAFLD).

Methods: In total, 97 T2DM patients were categorized into three groups based on hepatic ultrasonography: group A (those without NAFLD, n=30), group B (those with mild NAFLD, n=32), and group C (those with moderate-to-severe NAFLD, n=35). Our conventional echocardiographic parameters included transmitral peak early and late diastolic velocity (E and A), septal and lateral early (e') mitral annular diastolic tissue velocities, and left atrial maximum volume index (LAVImax). LV end-diastolic and -systolic volume, LV mass index (LVMI), and LV ejection fraction were measured using real-time three-dimensional echocardiography. The 3D-STE parameters included LV global radial strain (GRS), global longitudinal strain (GLS), global area strain (GAS), and global circumferential strain (GCS).

Results: Our results showed that in group C, GCS, GRS, GLS, GAS, and septal and lateral e' velocity decreased, whereas average E/e' and LAVImax increased compared to groups B and A (p<0.05). Multiple linear regression analysis showed that NAFLD is independently associated with 3D-STE parameters, and glycosylated hemoglobin also has negative impacts on all LV 3D strains.

Conclusion: When combined with conventional echocardiography, 3D-STE can assess LV function effectively in T2DM patients with NAFLD. Additionally, the severity of LV dysfunction in the moderate-to-severe NAFLD group (group C) was worse than the mild and absent NAFLD groups (groups A and B).

Citing Articles

Non-alcoholic fatty liver disease and LV diastolic dysfunction in patients with type 2 diabetes mellitus.

Faramarzpour M, Hosseiniazar M, Hooshmand Gharabagh L Caspian J Intern Med. 2024; 16(1):47-57.

PMID: 39619748 PMC: 11607126. DOI: 10.22088/cjim.16.1.47.


Additive effect of metabolic dysfunction-associated fatty liver disease on left ventricular function and global strain in type 2 diabetes mellitus patients: a 3.0 T cardiac magnetic resonance feature tracking study.

Tang X, Shi R, Jiang L, Yan W, Han P, Qian W Cardiovasc Diabetol. 2024; 23(1):317.

PMID: 39192259 PMC: 11350936. DOI: 10.1186/s12933-024-02410-z.


Value of 2D speckle tracking technique combined with real-time 3-dimensional echocardiography in the evaluation of the right atrial function in patients with 3-branch coronary artery disease without myocardial infarction.

Zhang S, Zhou Q, Li X, Wang Y, Ma L, Huang D Medicine (Baltimore). 2024; 103(18):e38058.

PMID: 38701248 PMC: 11062688. DOI: 10.1097/MD.0000000000038058.


Non-alcoholic Fatty Liver Disease and Its Association With Left Ventricular Diastolic Dysfunction: A Systematic Review.

Gohil N, Tanveer N, Makkena V, Jaramillo A, Awosusi B, Ayyub J Cureus. 2023; 15(8):e43013.

PMID: 37674936 PMC: 10477932. DOI: 10.7759/cureus.43013.


Feasibility study of automated cardiac motion quantification to assess left ventricular function in type 2 diabetes.

Li Y, Wu C, Li Y Sci Rep. 2023; 13(1):1101.

PMID: 36670174 PMC: 9859822. DOI: 10.1038/s41598-023-28262-3.


References
1.
Bugianesi E . Nonalcoholic fatty liver disease (NAFLD) and cardiac lipotoxicity: Another piece of the puzzle. Hepatology. 2007; 47(1):2-4. DOI: 10.1002/hep.22105. View

2.
Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X . Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol. 2006; 48(8):1688-97. DOI: 10.1016/j.jacc.2006.07.022. View

3.
Nesser H, Mor-Avi V, Gorissen W, Weinert L, Steringer-Mascherbauer R, Niel J . Quantification of left ventricular volumes using three-dimensional echocardiographic speckle tracking: comparison with MRI. Eur Heart J. 2009; 30(13):1565-73. DOI: 10.1093/eurheartj/ehp187. View

4.
Saccheri M, Cianciulli T, Lax J, Gagliardi J, Caceres G, Quarin A . Two-dimensional speckle tracking echocardiography for early detection of myocardial damage in young patients with Fabry disease. Echocardiography. 2013; 30(9):1069-77. DOI: 10.1111/echo.12216. View

5.
Ducas R, Tsang W, Chong A, Jassal D, Lang R, Leong-Poi H . Echocardiography and vascular ultrasound: new developments and future directions. Can J Cardiol. 2013; 29(3):304-16. DOI: 10.1016/j.cjca.2012.11.001. View